Guru Ownership Trend
Guru Analysis for aTyr Pharma, Inc. (ATYR)
aTyr Pharma, Inc. (ATYR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.6 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $1.36 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 426.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for aTyr Pharma, Inc. (ATYR)
Major holders include Cliff Asness ($1.56 M), Renaissance Technologies (RenTech) ($98,604), Steven Cohen ($22,248). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.81 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.36 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ATYR during the most recent reporting period.
Yes, 1 managers opened new positions in ATYR, and 2 increased their existing holdings. The total reported buy value was $1.36 M.